American Society of Hirudotherapy

Chronic Otitis Externa (Investigational Adjunct)

Investigational adjunct for refractory chronic otitis externa; topical antimicrobials, aural toilet, and predisposing-factor management remain evidence-based.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 12, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for chronic otitis externa. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.
What evidence exists?
Tier C (investigational). No controlled trial of leech therapy in chronic otitis externa was identified in our literature search; the few reports found give little outcome data and none is specific to chronic disease. Evidence-based first-line management is otologic examination to identify the cause (eczematous, fungal, bacterial, foreign body, underlying cholesteatoma), aural toilet, topical corticosteroid drops for inflammatory disease, topical antifungal for otomycosis, topical antibiotic-steroid combinations for bacterial disease, and identification and avoidance of triggers (water exposure, cotton swab use, hearing aids).
Main risks
  • Bleeding from each bite site for 6 to 10 hours after the leech detaches
  • Iron-deficiency anemia from cumulative blood loss across multiple sessions
  • Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
  • Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
  • Small Y-shaped bite marks or skin colour changes at the bite sites, which usually fade over weeks to months
  • Local pain, bruising, swelling, or itching for 1 to 3 days after each session
  • Periauricular placement near the ear canal carries bleeding and infection risks in already inflamed tissue
  • Aeromonas may add a second pathogen to an already infected ear
  • Bites cannot be placed inside the ear canal — that is unsafe
Who should not consider this
  • Patients without ENT evaluation to confirm the diagnosis and rule out malignant otitis externa, cholesteatoma, or tumor
  • Patients with active fungal or bacterial infection (need targeted topical therapy)
  • Diabetic or immunocompromised patients with otitis externa (high risk of skull-base osteomyelitis)
  • Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran or heparin (daily aspirin alone is not a contraindication: tell your doctor, who starts with fewer leeches)
  • People with hemophilia or any other inherited bleeding disorder
  • Patients with anemia
  • People with an active infection at the planned application site
What to ask your clinician
  • Has ENT evaluated my ear canal and ruled out malignant otitis externa or other serious causes?
  • Have appropriate topical antibiotic, antifungal, or steroid drops been tried?
  • Have aural toileting and trigger avoidance been addressed?
  • What is the published evidence base for leeches in otitis externa?
  • Where exactly will leeches be placed, and how is proximity to the ear canal managed?
  • How will worsening infection be detected during the course?
When to seek urgent care
  • Bleeding from a bite site that soaks through more than one dressing per hour
  • Bleeding that continues more than 24 hours after the leech detached
  • Spreading redness, warmth, swelling, pus, or red streaks around any bite site
  • Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
  • Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
  • Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
  • Severe ear pain disproportionate to physical findings (possible malignant otitis externa, especially in diabetics)
  • Facial weakness, severe headache, or fever (could indicate skull-base osteomyelitis)
  • New hearing loss, vertigo, or persistent discharge

What this does NOT mean

  • It does not mean leech therapy is FDA-cleared for otitis externa — the only FDA clearance is venous congestion in microsurgical reconstruction (K040187, June 2004).
  • It does not replace targeted antibiotic, antifungal, or steroid topical therapy.
  • It does not exclude malignant otitis externa, cholesteatoma, or ear canal tumor.
  • It does not address triggers (water, cotton swabs, hearing aids).
  • No controlled trial of leech therapy in chronic otitis externa was identified, and it adds risks in an already inflamed area.

Clinical Profile

Category
ENT
ICD-10
H60.60, H60.61, H60.62, H60.63
Safety tier
High

Evidence Summary

Chronic otitis externa is inflammation of the external ear canal lasting beyond 6 weeks, often with bacterial (Pseudomonas, Staphylococcus) or fungal (Aspergillus, Candida) component. Evidence-based management includes microscopic aural toilet, topical antimicrobial drops (fluoroquinolone-corticosteroid combinations for bacterial, antifungal for fungal), wick placement in canal-stenotic cases, and addressing predisposing factors (water exposure, dermatitis of the canal, cerumen pathology, hearing-aid use). Necrotizing otitis externa in diabetic or immunocompromised patients is a surgical emergency. No controlled trial of leech therapy for chronic otitis externa was identified in PubMed, Europe PMC or Russian-language sources. The few reports found give little outcome data and none is specific to chronic disease: a clinical report from Donetsk that includes acute external otitis among the ear diseases treated (Seleznev 1992), and a report of 68 patients with otitis externa of unspecified type from Uzbekistan (Bakhritdinov 2020) that gives no outcome figures. The external auditory canal is anatomically inaccessible and high-risk; the periauricular region carries facial nerve and arterial risk.

What the books describe

Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.

  • Baskova and Isakhanyan do not write about chronic otitis externa: the book names acute otitis externa, which they list among the indications for hirudotherapy[B1].
  • They describe a study by Seleznev and co-authors (1992) in 273 patients with acute otitis externa, chronic otitis media and ear noise (tinnitus): in some patients leech saliva was introduced into the skin without blood, by microelectrophoresis, in others ordinary hirudotherapy sessions were carried out, and in the third group ordinary drug treatment was used[B1].
  • Baskova and Isakhanyan write that the results of these “pilot clinical trials” showed that leech saliva acts primarily on the microcirculation; in addition, by their description, in all cases the number of microorganisms on the skin of the external auditory canal decreased[B1].
  • In Baskova and Isakhanyan’s account, the results of this study are not separated by diagnosis, so it does not show what exactly happened in patients with otitis externa or how long they were followed[B1].
  • Michalsen, in chapter 10, describing this study by Baskova’s team, writes that hirudotherapy showed significant superiority in alleviating the symptoms of otitis externa and tinnitus but had no demonstrable effect in otitis media; he qualifies this by saying that the results should be interpreted with caution, especially for tinnitus; Michalsen does not write about chronic otitis externa[B3].
  • Baskova and Isakhanyan advise refraining from hirudotherapy at high body temperature, while Flecken and Michalsen write that in the acute stage of infectious diseases it may, according to experience, cause weakness and impair wound healing[B1][B3].
  • Among the contraindications, Baskova and Isakhanyan, like Flecken and Michalsen in chapter 8 of the book by Michalsen et al., name hemophilia, anemia and concurrent use of anticoagulants (drugs that reduce blood clotting)[B1][B3].

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Active bacterial or fungal otitis externa
  • Necrotizing (malignant) otitis externa — surgical emergency
  • Tympanic membrane perforation
  • Ear canal placement
  • Cholesteatoma or other middle-ear pathology
  • Hearing aid in situ on affected side

Related Conditions

References

  • [B1]

    Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]

    Москва: Монолит(2004)https://search.rsl.ru/ru/record/01007959553

    Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.

  • [B3]

    Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy

    Stuttgart — New York: Thieme(2007)https://books.google.com/books?vid=ISBN9781588905635

    ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.

The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.